Remdesivir-related adverse reactions in patients admitted for COVID-19 at Hospital Universitario de la Princesa

被引：0
|
作者：
Maria Campodonico, Diana [1 ]
Gomez Fernandez, Antia [1 ]
Casajus Rey, Ana [1 ]
Mejia Abril, Gina [1 ]
Camargo Mamani, Paola Agueda [1 ]
Ochoa Mazarro, Maria Dolores [1 ]
Alvarez Montero, Miguel [1 ]
Abad Santos, Francisco [1 ]
Lopez Raigada, Azahara [1 ]
机构：
[1] Hosp Univ Princesa, Dept Clin Pharmacol, Madrid, Spain
来源：
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 2021年 / 77卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
68
引用
收藏
页码：20 / 21
页数：2
相关论文
共 50 条
  • [1] ADVERSE REACTIONS TO DRUGS AS A CAUSE OF HOSPITAL ADMISSION HOSPITAL UNIVERSITARIO DE LA PRINCESA - MADRID
    Acosta, A. R.
    Valdez Acosta, S. E.
    Rojano, E. G.
    Santos, F. A.
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 37 - 37
  • [2] ADVERSE DRUG REACTIONS AS A CAUSE OF HOSPITAL ADMISSION HOSPITAL UNIVERSITARIO DE LA PRINCESA - MADRID
    Rivas, A.
    Valdez, S.
    Gonzalez, E.
    Abad, F.
    [J]. CLINICAL THERAPEUTICS, 2015, 37 (08) : E150 - E151
  • [3] Remdesivir-related acute kidney injury in patients with COVID-19
    [J]. Reactions Weekly, 2020, 1826 (1) : 5 - 5
  • [4] Remdesivir-Related Cardiac Adverse Effects in COVID-19 Patients: A Case-Control Study
    Abedipour, Fatemah
    Mirzaei, Hossein Hadavand
    Ansari, Hossein
    Ehsanzadeh, Neda
    Rashki, Amin
    Vahedi, Mohammad Mahdi
    Rashki, Asma
    [J]. DRUG RESEARCH, 2024, 74 (06) : 290 - 295
  • [5] SEVERE DERMATOLOGIC REACTIONS ASSOCIATED WITH DRUGS IDENTIFIED IN THE HOSPITAL UNIVERSITARIO DE LA PRINCESA
    Valdez, S.
    Rivas, A.
    Gonzalez, E.
    Abad-Santos, F.
    Ochoa, D.
    [J]. CLINICAL THERAPEUTICS, 2015, 37 (08) : E70 - E71
  • [6] Potential remdesivir-related transient bradycardia in patients with coronavirus disease 2019 (COVID-19)
    Pallotto, Carlo
    Suardi, Lorenzo R.
    Gabbuti, Andrea
    Esperti, Sara
    Mecocci, Lorenzo
    Blanc, Pierluigi
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (05) : 2631 - 2634
  • [7] Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19
    Ader, Florence
    Bouscambert-Duchamp, Maude
    Hites, Maya
    Peiffer-Smadja, Nathan
    Mentre, France
    Burdet, Charles
    [J]. LANCET INFECTIOUS DISEASES, 2022, 22 (06): : 764 - 765
  • [8] Incidence of adverse reactions in healthy volunteers studies in hospital de la Princesa (Madrid)
    Martín-Serrano, A. Nevado
    Ochoa, M. D.
    Novalbos, J.
    López Rodriguez, R.
    Pelegrina, M. L.
    Abad-Santos, F.
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2006, 99 : 25 - 25
  • [9] Remdesivir-related cost-effectiveness and cost and resource use evidence in COVID-19: a systematic review
    Murton, Molly
    Drane, Emma
    Jarrett, James
    Cornely, Oliver A.
    Soriano, Alex
    [J]. INFECTION, 2023, 51 (02) : 285 - 303
  • [10] Remdesivir-related cost-effectiveness and cost and resource use evidence in COVID-19: a systematic review
    Molly Murton
    Emma Drane
    James Jarrett
    Oliver A. Cornely
    Alex Soriano
    [J]. Infection, 2023, 51 : 285 - 303
12345